Depigmented Allergoids Reveal New Epitopes with Capacity to Induce IgG Blocking Antibodies (original) (raw)

Conversion of grass pollen allergen-specific human IgE into a protective IgG1 antibody

Peter Steinberger

European Journal of Immunology, 2002

View PDFchevron_right

Immunologic characterization of monoclonal antibodies that modulate human IgE binding to the major birch pollen allergen Bet v 1☆, ☆☆, ★, ★★

Jean-jacques Pin

Journal of Allergy and Clinical Immunology, 1997

View PDFchevron_right

Monitoring the epitope recognition profiles of IgE, IgG1, and IgG4 during birch pollen immunotherapy

Heimo Breiteneder

The Journal of allergy and clinical immunology, 2015

View PDFchevron_right

Dominant Epitopes and Allergic Cross-Reactivity: Complex Formation Between a Fab Fragment of a Monoclonal Murine IgG Antibody and the Major Allergen from Birch Pollen Bet v 1

osman mirza

The Journal of Immunology, 2000

View PDFchevron_right

Filling the Antibody Pipeline in Allergy: PIPE Cloning of IgE, IgG1 and IgG4 against the Major Birch Pollen Allergen Bet v 1

Rodolfo Bianchini

International Journal of Molecular Sciences

View PDFchevron_right

Vaccination for birch pollen allergy Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1

Morten Svenson

Molecular Immunology, 2003

View PDFchevron_right

Molecular characterization of human IgG monoclonal antibodies specific for the major birch pollen allergen Bet v 1. Anti-allergen IgG can enhance the anaphylactic reaction

Peter Steinberger

FEBS Letters, 2000

View PDFchevron_right

Confirmation of immuno-reactivity of the recombinant major birch pollen allergen Bet v 1a by affinity-CIEF

Andreas Rizzi

ELECTROPHORESIS, 2009

View PDFchevron_right

Comparison of allergenicity and immunogenicity of an intact allergen vaccine and commercially available allergoid products for birch pollen immunotherapy

Helene Henmar

Clinical & Experimental Allergy, 2007

View PDFchevron_right

A Nonallergenic Birch Pollen Allergy Vaccine Consisting of Hepatitis PreS-Fused Bet v 1 Peptides Focuses Blocking IgG toward IgE Epitopes and Shifts Immune Responses to a Tolerogenic and Th1 Phenotype

Ines Swoboda

The Journal of Immunology, 2013

View PDFchevron_right

Can IgE-mediated allergic diseases be prevented by using allergen-specific IgG antibodies?

Hiroshi Tachibana

Medical Hypotheses, 2011

View PDFchevron_right

Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2

Fatima Ferreira

Journal of allergy and …, 1996

View PDFchevron_right

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy

Michael Breitenbach

Journal of Experimental Medicine, 1996

View PDFchevron_right

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for …

Fatima Ferreira

The Journal of …, 1996

View PDFchevron_right

Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1

Vincenzo Visco

Journal of immunology (Baltimore, Md. : 1950), 1996

View PDFchevron_right

Allergen-Specific Immunotherapy Follow-Up by Measuring Allergen-Specific IgG as an Objective Parameter

Ernesto Taketomi

Immunotherapy - Myths, Reality, Ideas, Future

View PDFchevron_right

A molecular model of type I allergy: Identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcϵRI interaction and reacts with receptor-bound IgE

Ken Roux

Journal of Allergy and Clinical Immunology, 2001

View PDFchevron_right

Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen

Arnulf Hartl

Journal of Allergy and Clinical Immunology, 1999

View PDFchevron_right

Comparison of Immunoglobulin E Measurements on IMMULITE and ImmunoCAP in Samples Consisting of Allergen-Specific Mouse-Human Chimeric Monoclonal Antibodies towards Allergen Extracts and Four Recombinant Allergens

Pal Szecsi

International Archives of Allergy and Immunology, 2013

View PDFchevron_right

Monoclonal antibodies to three distinct epitopes on human IgE: Their use for determination of allergen-specific IgE

João Carlos

Journal of Immunological Methods, 1984

View PDFchevron_right

Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2

Fatima Ferreira

Journal of allergy and …, 1996

View PDFchevron_right

Human recombinant antibody fragments specific for a rye-grass pollen allergen: Characterization and potential applications

lol no

Molecular Immunology, 1996

View PDFchevron_right

Induction of Blocking Antibodies with T Cell Epitope-Containing Hypoallergenic Recombinant Bet v 1 Fragments

FERAH BUDAK

International Archives of Allergy and Immunology, 2001

View PDFchevron_right

NOVEL TREATMENT STRATEGIES AND REGULATION OF IgE-MEDIATED ALLERGIC

Sarah Thunberg

2008

View PDFchevron_right

T Cell Epitope-Containing Hypoallergenic Recombinant Fragments of the Major Birch Pollen Allergen, Bet v 1, Induce Blocking Antibodies

FERAH BUDAK

The Journal of Immunology, 2000

View PDFchevron_right

Cytokine and Antibody Responses in Birch-Pollen-Allergic Patients Treated with Genetically Modified Derivatives of the Major Birch Pollen Allergen Bet v 1

Guro Gafvelin

International Archives of Allergy and Immunology, 2005

View PDFchevron_right

Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract

ronald dahl

The Journal of allergy and clinical immunology, 2015

View PDFchevron_right

Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimer

Ines Swoboda

Molecular Immunology, 2011

View PDFchevron_right

Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome

Wolf-Meinhard Becker

Clinical & Experimental Allergy, 1999

View PDFchevron_right

Characterization of the protective and therapeutic efficiency of a DNA vaccine encoding the major birch pollen allergen Bet v 1a

Fatima Ferreira

Allergy, 2004

View PDFchevron_right